BCV
VNDA icon

Banque Cantonale Vaudoise’s Vanda Pharmaceuticals VNDA Stock Holding History

Banque Cantonale Vaudoise’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,276
Closed -$69K – 1024
2024
Q2 		$69K Buy
12,276
+684
+6% +$3.53K ﹤0.01% 748
2024
Q1 		$48K Buy
11,592
+809
+8% +$3.24K ﹤0.01% 792
2023
Q4 		$46K Hold
10,783
– – ﹤0.01% 820
2023
Q3 		$47K Hold
10,783
– – ﹤0.01% 975
2023
Q2 		$71K Buy
+10,783
New +$69.1K ﹤0.01% 914

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's VNDA Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Vanda Pharmaceuticals (VNDA) in Q3 2024, closing a stake of 12,276 shares — an estimated $69K sold.

Banque Cantonale Vaudoise first reported a position in VNDA in Q2 2023 and held it in 5 quarters. The position peaked at $71K in Q2 2023. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining Vanda Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 12,276 Vanda Pharmaceuticals shares in Q3 2024, an estimated $69K.
  • Banque Cantonale Vaudoise first reported a position in Vanda Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Banque Cantonale Vaudoise's Vanda Pharmaceuticals position peaked at $71K in Q2 2023.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.